Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Kankakee-Bradley, IL Metro Edition
Focus: LIFE SCI
Kankakee CRA pay surges as local labor market stays volatile.
4.1%
Kankakee unemployment rate
Down from 7.0% in Feb 2026, up from 5.5% Sept 2025
-2.1%
Metro nonfarm payroll change
Year-over-year through Sept 2025, largest decline in IL
$83,763
CRA advertised pay, metro
vs $90,956 national median, up significant
-94,600 workers
Illinois labor force change
Year-over-year through Aug 2026, tightens talent pipeline
This Month's Takeaways
CRA pay is catching up to national levels fast.
Metro CRA advertised pay rose to a $83,763 median, a significant increase that closes much of the gap with the $90,956 national figure. This is consistent with tightening local clinical talent supply as biopharma employers compete against broader regional manufacturing hiring driven by the EV-battery facility buildout.
Validation Engineer pay gap may reflect muted local leverage, not lower demand.
Metro Validation Engineer pay sits $8,730 below the national median and has stayed stable while national pay rose moderately. Smaller local employer base likely limits bidding wars seen in larger biopharma hubs, but risks losing engineers to remote-eligible roles priced at national rates.
Kankakee's job losses complicate build-vs-outsource math.
Total nonfarm payrolls fell 2.1% year-over-year even as unemployment swung from 5.5% to 7.0% and back to 4.1% within months, signaling volatile labor supply rather than steady availability. Life sci leaders weighing in-house quality or manufacturing expansion should treat local hiring timelines as less predictable than state-level data implies.
Statewide biotech wage compression narrows the outsourcing calculus.
Illinois biotech compensation averages $76,680 against a $153,000 average across all life sciences roles statewide, a wide tier gap that makes senior scientist and quality retention economically rational for larger operations but cost-prohibitive for smaller Kankakee-area employers. This may push smaller biopharma sites toward CDMO/CRO partnerships for specialized functions rather than building internal depth.
Local Labor Conditions
Kankakee's labor market continues to diverge from state and national trends, with the metro's unemployment rate climbing to 7.0% in February 2026 before recent county-level data showed partial recovery to 4.1% in July, reflecting ongoing volatility tied to a -2.1% year-over-year contraction in total nonfarm payrolls. CSL Behring and MilliporeSigma anchor local biopharma employment even as the broader metro absorbs disruption from a $2 billion EV-battery facility build-out competing for skilled manufacturing and technical labor across the region.
Leadership & Talent Implications
Clinical Research Associate advertised pay in Kankakee has moved up significantly to a $83,763 median, narrowing the gap with the $90,956 national figure and signaling that even a smaller biopharma labor pool is pricing talent closer to national benchmarks as CSL Behring and MilliporeSigma compete for scarce clinical and quality staff. Validation Engineer pay holding stable locally at $99,647 against a moderately rising national median of $108,377 suggests Kankakee employers retain a cost advantage on engineering-adjacent roles even as regional manufacturing demand intensifies from the EV-battery project. Organizations should evaluate whether CRA compensation increases reflect durable scarcity or short-term competitive bidding before resetting base pay structures across clinical functions.
